Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
When you're eating less food overall, every bite matters more
Lillys blockbuster GLP-1 tirzepatide appears poised to become the next major HFpEF drug, after topline results from the SUMMIT trial showed that it significantly improved both outcomes and symptoms among patients with heart failure with preserved ejection fraction and obesity
Most of the studies use between 1-3 grams of L-carnitine
An in vitro study found that treating lung fibroblasts from COPD patients with GHK-Cu helped restore their function
The FDA strengthened Cymbaltas label to include more details about withdrawal symptoms
US$ 26.57
US$ 25.63
US$ 25.27
US$ 26.68
US$ 27.79
US$ 20.99
US$ 29.84
US$ 22.90
